This symposium will review the neurobiological and psychological pathways associated with appetite and weight gain and how the interaction of lifestyle management and pharmacotherapy can be leveraged to attain sustainable long-term control of overweight and obesity.

Sponsored by Haymarket Medical Education

Supported by an Educational Grant from Novo Nordisk


7:00 PM – 7:30 PM Registration and Dinner

7:30 PM – 7:35 PM Welcome / Introductions / Pre-test

7:35 PM – 8:45 PM Presentation Topics

  • Unmet Needs in the Management of Chronic Obesity
  • Neurobiological Pathways and Pharmacotherapeutic Approaches
  • Psychologic Pathways and Environmental Triggers: Behavioral Approaches
  • Integrating Pharmacotherapy with Lifestyle Interventions: Tailoring Treatment to Individual Needs

8:45 PM – 9:00 PM Panel Discussion/Q & A Session / Post-test

Learning Objectives:

  • Describe the complex and heterogeneous mechanisms that contribute to the chronicity of obesity
  • Identify how pharmacotherapies can address perturbations of the neural and hormonal pathways that regulate appetite and energy balance
  • Develop evidence-based, individualized treatment approaches, including the incorporation of pharmacotherapy with behavioral therapy, to achieve clinically meaningful and sustainable weight loss
  • Implement patient-centric strategies to overcome barriers to weight loss, using a shared decision-making approach that destigmatizes obesity and promotes weight loss as a path to improved health

Accreditation Statement

Haymarket Medical Education (HME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

HME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.